HEALTH

Moderna Gives Fresh Insights Into Its Vaccine

Moderna Gives Fresh Insights Into Its Vaccine

OpenLife Nigeria has gathered that Moderna has said two 25-microgram doses of its Covid-19 vaccine for children ages 6 months through 5 years old provid a similar immune response to two 100-microgram doses for adults ages 18 to 25, indicating that the benefit conferred to young adults is also conferred to young children.
The two doses of vaccine are given to children 28 days apart.
The data showed “a robust neutralizing antibody response” and “a favorable safety profile,” according to a company news release issued Wednesday.
Based on the data, Moderna said it will ask the US Food and Drug Administration to authorize the use of the vaccine in this younger age group in the coming weeks.
“Given the need for a vaccine against COVID-19 in infants and young children we are working with the U.S. FDA and regulators globally to submit these data as soon as possible,” Moderna CEO Stéphane Bancel said. “We believe these latest results … are good news for parents of children under 6 years of age.”
The vaccine was not all that effective at preventing Covid-19 infections caused by the Omicron variant, which predominated in the US during the study. For children ages 6 months through 1 year old, the efficacy was 43.7%. For children ages 2 through 5, the efficacy was 37.5%.
Moderna said the lower efficacy was still statistically significant and consistent with how vaccinated adults have fared with the Omicron variant.
Moderna said it is preparing to evaluate the potential of a booster shot for all children 6 months and older, which would target the original strain of the virus as well as the Omicron variant.
The data is based on a group of 6,900 children ages 6 months through 5 years old. The majority of adverse reactions were mild or moderate, and were more frequent after the second shot. Moderna said no deaths and no cases of myocarditis or pericarditis were reported. Myocarditis is inflammation of the heart muscle and pericarditis is inflammation of the heart lining.
Moderna also announced that it has initiated a submission to the FDA for emergency use authorization of the company’s Covid-19 vaccine for children ages 6 through 11 years old. Children that age would get two shots of a larger 50-microgram version of the vaccine. Moderna also said it provided the FDA with additional follow-up data on its vaccine for children ages 12 to 17. Children that age would get two shots of a larger 100-microgram version of the vaccine.
Last month, the FDA postponed a meeting of its vaccine advisers to consider Pfizer/BioNTech’s Covid-19 vaccine for children younger than 5, and requested additional data on third doses. The companies have said they expect that data to be ready by early April.
Source: CNN

Share This
Openlife Reporter

Recent Posts

NASRE Foundation Hosts Third Media Outreach, Prioritizes Health, Insurance, And Multiple Income Streams For Journalists

NASRE Foundation Hosts Third Media Outreach   OpenLife Nigeria reports that the Nigerian Association of…

10 hours ago

ZENITH BANK REWARDS HACKATHON WINNERS WITH N77.5M CASH PRIZE AT ZENITH TECH FAIR 4.0

ZENITH BANK REWARDS HACKATHON WINNERS OpenLife Nigeria reports that a total sum of N77.5 million…

1 day ago

Boost In Oil Production: NNPC’s Utapate Crude Grade Hits Global Oil Market As OML 13 Asset Eyes 80,000 bpd By End Of 2025

Boost In Oil Production OpenLife Nigeria reports that in a major boost for Nigeria’s crude…

3 days ago

Health, Insurance, Entrepreneurship Lectures To Take Centre Stage At NASRE’s End- Of-Year Supports To Journalists With Challenges

Health OpenLife Nigeria reports that the Nigerian Association of Social and Resourceful Editors (NASRE) has…

3 days ago

We Are Building A New Police Free Of Corruption But Full Of Vigor, Determination To Serve—Argungu

We Are Building A New Police OpenLife Nigeria reports that the Police Service Commission today,…

4 days ago

Helen Paul Receives Georgia Citizen Award

 Helen Paul Receives Georgia Citizen Award     Popular entertainer and educationist, Prof Helen Paul…

4 days ago

This website uses cookies.